NCT01438528View on ClinicalTrials.gov

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Growth Disorders
Interventions
DEVICE

easypod ™

Saizen (Somatotropin) as per Summary of Product Characteristics administered by easypod™

Trial Locations (1)

Unknown

For Recruiting Locations in China, Please Contact the Merck KGaA Communication Center

All Listed Sponsors
collaborator

Merck Serono Co., Ltd., China

INDUSTRY

lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT01438528 - Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment | Biotech Hunter | Biotech Hunter